Opiant Pharmaceuticals Inc

NASDAQ:OPNT   4:00:00 PM EDT
20.16
-0.06 (-0.30%)
7:47:46 PM EDT: $21.16 +1.00 (+4.96%)
Earnings Announcements

Opiant Pharmaceuticals Says Qtrly Net Loss Per Common Share $1.93

Published: 11/14/2022 07:21 GMT
Opiant Pharmaceuticals Inc (OPNT) - Opiant Pharmaceuticals Announces Third Quarter 2022 Financial Results.
Opiant Recorded $0.2 Million of Revenue in Q3, Compared to $16.3 Million for Three Months Ended September 30, 2021.
Qtrly Net Loss per Common Share $1.93.
Revenue is expected to be $1.1 Million
Adjusted EPS is expected to be -$2.04

Next Quarter Revenue Guidance is expected to be $2.3 Million
Next Quarter EPS Guidance is expected to be -$2.14

More details on our Analysts Page.